Abstract
Intestinal microbial dysbiosis has been described in HIV-1-infected individuals and may underlie persistent inflammation in chronic infection, thereby contributing to disease progression. Herein, we induced an HIV-1-like intestinal dysbiosis in rhesus macaques with vancomycin treatment and assessed the contribution of dysbiosis to SIV disease progression. Dysbiotic and control animals had similar disease progression, indicating that intestinal microbial dysbiosis similar to that observed in HIV-infected individuals is not sufficient to accelerate untreated lentiviral disease progression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have